Skip to main content

Idenix Pharmaceuticals Inc (NASDAQ:IDIX) Investor Investigation Concerning Potential Breaches Of Fiduciary Duties In Acquisition Announced

  • If you purchased shares of Idenix Pharmaceuticals Inc (NASDAQ:IDIX) and currently hold any of those NASDAQ:IDIX shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

June 13, 2014 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Idenix Pharmaceuticals Inc (NASDAQ:IDIX) shares, was announced concerning whether the takeover of Idenix Pharmaceuticals Inc . by Merck for $24.50 per shares is unfair to NASDAQ:IDIX stockholders. The investigation by a law firm concerns whether certain officers and directo...



You must register (for free) or login to view the entire investigation.